MetLife Investment Management, LLC - Dec 14, 2020 Form 4 Insider Report for Neuberger Berman High Yield Strategies Fund Inc. (NHS)

Role
10%+ Owner
Signature
/s/ Israel Grafstein, Chief Compliance Officer of MetLife Investment Management, LLC
Stock symbol
NHS
Transactions as of
Dec 14, 2020
Transactions value $
-$53,002,712,952,189
Form type
4
Date filed
6/10/2022, 04:45 PM
Previous filing
Jun 10, 2022
Next filing
May 26, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHS Floating Rate Senior Note, Series A Note, Due Sep. 18, 2023 Other -$7.83T -2.79M -35% $2,802,902.78* 5.19M Dec 14, 2020 See Footnotes F1, F3, F4, F5
transaction NHS Floating Rate Senior Note, Series A Note, Due Sep. 18, 2023 Other -$9.54T -3.08M -35% $3,092,858.28* 5.73M Dec 14, 2020 See Footnotes F1, F3, F4, F5
transaction NHS Floating Rate Senior Note, Series A Note, Due Sep. 18, 2023 Other -$21.4T -4.62M -35% $4,635,310.19* 8.58M Dec 14, 2020 See Footnotes F1, F3, F4, F5
transaction NHS Series C Mandatory Redeemable Preferred Shares Other -$12.3T -992K -20% $12,431,997.43* 3.97M Dec 14, 2020 See Footnotes F2, F3, F4, F5
transaction NHS Series C Mandatory Redeemable Preferred Shares Other -$462B -192K -20% $2,406,193.05* 768K Dec 14, 2020 See Footnotes F2, F3, F4, F5
transaction NHS Series C Mandatory Redeemable Preferred Shares Other -$1.41T -336K -20% $4,210,837.84* 1.34M Dec 14, 2020 See Footnotes F2, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Floating Rate Senior Notes, Series A Notes, due September 18, 2023 ("Notes") were redeemed, in part, by the Issuer pursuant to a partial prepayment of the principal plus accrued and unpaid interest.
F2 These Series C Mandatory Redeemable Preferred Shares ("Series C MRPS") were redeemed, in part, by the Issuer at a price equal to the liquidation preference of $12.50 per share plus accumulated and unpaid dividends.
F3 This price reflects the aggregate amount received in exchange for the redemption.
F4 These Notes and Series C MRPS are held directly by clients for whom the Reporting Person serves as investment manager.
F5 The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.